InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Prygocki Mark A Sr, 董事. Director active across 1 company, notably Clarus Therapeutics Holdings, Inc.. Aggregated, 2 filings have been published. Activity tracked since 12 December 2021. The latest transaction was filed on 7 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Prygocki Mark A Sr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
1,922 股0Common StockSEC:0000899243-22-021761:0
3,844 股0Common StockSEC:0000899243-21-048213:0
2 条申报中的 2 条
About Prygocki Mark A Sr
Mark A. Prygocki Sr is a Director at Clarus Therapeutics Holdings, Inc. In this role, he participates in the governance of the company, which specializes in developing medical treatments. Prygocki brings his expertise in corporate strategy, contributing to the direction and growth of Clarus Therapeutics.
